Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation

Circulation: Cardiovascular Imaging

Volumn 7, Issue 4, 2014, Pages 755-756

  Indolf, Ciro ^a   Mongiardo, Annalisa ^a   Spaccarotella, Carmen ^a   Caiazzo, Gianluca ^a   Torella, Daniele ^a   De Rosa, Salvatore ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Coronary restenosis; Tissue scaffold; Tomography, optical coherence

Indexed keywords

CORONARY RESTENOSIS; TISSUE SCAFFOLD; TOMOGRAPHY, OPTICAL COHERENCE;

ABSORBABLE IMPLANTS; AGED; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; MALE; NEOINTIMA; PROSTHESIS DESIGN; PROSTHESIS FAILURE; TIME FACTORS; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84905823644     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.114.001727     Document Type: Note

References (4)

1. Indolf C, Pavia M, Angelillo IF. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol. 2005;95:1146-1152.
2. Curcio A, Torella D, Indolf C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011;75:1287-1296.
3. Brugaletta S, Heo JH, Garcia-Garcia HM, Farooq V, van Geuns RJ, de Bruyne B, Dudek D, Smits PC, Koolen J, McClean D, Dorange C, Veldhof S, Rapoza R, Onuma Y, Bruining N, Ormiston JA, Serruys PW. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect fnding of vascular reparative therapy? Eur Heart J. 2012;33:1325-1333.
4. Ormiston JA, Serruys PW, Onuma Y, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Garcia-Garcia HM. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv. 2012;5:620-632.